Cephea Early Feasibility Study
NCT: NCT05061004 · RECRUITING
広告
NCT識別子NCT05061004
ステータスRECRUITING
開始日2022-04-28
完了2031-03-01
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated
概要
The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。